Pharmacovigilance and Pharmacoepidemiology: Public Health and Safety

56K

views

108

authors

17

articles

Editors

3

Thierry Trenque

Centre Hospitalier Universitaire de Reims

Eugene Van Puijenbroek

Netherlands Pharmacovigilance Centre Lareb

Moustapha Dramé

University Hospital of Martinique

Impact

About

Pharmacovigilance has historically been based on spontaneous reports. The World Health Organisation (WHO) defines pharmacovigilance as "the science and activities relating to detection, assessment, understanding and prevention of adverse effects or any medicine-related problem" (WHO 2004).

Pharmacoepidemiological studies can supplement the role of identification, as the spontaneous reporting of adverse drug reactions and conventional pharmacovigilance, can alert us to other, potentially more major, problems, medicine-related or otherwise.

Interest in coupling signal detection methods in large pharmacovigilance databases has been consistently demonstrated, for example, in the use of bisphosphantes when treating osteonecrosis of the jaw, and in the correlation between withdrawal syndrome and antidepressants.

This Research Topic aims to closely look at pharmacovigilance and pharmacoepidemiology, and their resulting influence on public health and safety. This Research Topic welcomes submissions on the following subjects:

? Special population - product use and safety:

- elderly

- pediatric

- pregnant women

? Signal detection, Pharmacovigilance activities.

? Biosimilars: product use and safety.

? Vaccines: product use and safety.

? Management and utility of Pharmacovigilance activities.

Pharmacovigilance has historically been based on spontaneous reports. The World Health Organisation (WHO) defines pharmacovigilance as "the science and activities relating to detection, assessment, understanding and prevention of adverse effects or any medicine-related problem" (WHO 2004).

Pharmacoepidemiological studies can supplement the role of identification, as the spontaneous reporting of adverse drug reactions and conventional pharmacovigilance, can alert us to other, potentially more major, problems, medicine-related or otherwise.

Interest in coupling signal detection methods in large pharmacovigilance databases has been consistently demonstrated, for example, in the use of bisphosphantes when treating osteonecrosis of the jaw, and in the correlation between withdrawal syndrome and antidepressants.

This Research Topic aims to closely look at pharmacovigilance and pharmacoepidemiology, and their resulting influence on public health and safety. This Research Topic welcomes submissions on the following subjects:

? Special population - product use and safety:

- elderly

- pediatric

- pregnant women

? Signal detection, Pharmacovigilance activities.

? Biosimilars: product use and safety.

? Vaccines: product use and safety.

? Management and utility of Pharmacovigilance activities.

Download ebook

Share

Editors

Thierry Trenque

Centre Hospitalier Universitaire de Reims

Eugene Van Puijenbroek

Netherlands Pharmacovigilance Centre Lareb

Moustapha Dramé

University Hospital of Martinique

Impact

55,992 Total views

39,064 Article views

15,425 Article downloads

1,503 Topic views

Published In

Journal Thumbnail

Frontiers in Pharmacology

Pharmacoepidemiology

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic